From Cancer Research UK
The Government’s view
Professor Mike Richards, National Cancer Director, kicked off the session. He acknowledged that the UK spends less on healthcare as a whole than many other European countries. On top of this, we spend proportionally less on cancer care than many of our EU counterparts.
According to the latest figures, around 5 per cent of the NHS spend is on cancer, equating to around £76 per head each year in England ….
Clearly there is a need to increase spend in the NHS on cancer – particularly when the demographics and new advances in cancer drugs are taken into account. As the population ages, cancer is getting more common – Professor Richards commented that the incidence of the disease is increasing at a rate of around 1.5 per cent each year. This means there will inevitably be more people needing cancer care services.
And with great strides in cancer research, many new drugs and diagnostic tests are coming through – offering new hope to people touched by cancer – but at a price. On top of this, the NHS needs to consider the increasing cost of follow up care for cancer survivors (’survivorship care’) – as more and more people survive cancer.
So cancer care costs are certain to increase in the future, and these will need to be met through boosting spending and efficiency in the NHS.
Compare the £76 per head spent on Cancer alone by the NHS to the cost of effective supplementation with Vitamin D3 – approximately £10 per head, per annum.
Now factor in Diabetes:
The NHS is spending £1m an hour, 10% of its yearly budget, treating diabetes and its complications, according to a new report.
Despite advances in detection and treatment, incidence of the disease – which causes heart attacks, stokes and blindness – is spiralling.
GPs are still missing telltale symptoms which mean the disease may remain undetected for many years until irreversible damage has been done, said campaigning charity Diabetes UK.
Some 2.3million people in the UK are already diagnosed but the charity estimated the number of diagnosed and “hidden” diabetics will top 4million by 2025.
The report also revealed one in 10 people in hospital in the UK have diabetes and 60% of inpatients with diabetes have been admitted as emergencies. The total cost to the NHS equates to £9bn-a-year.
Source: The Guardian.
This is another £140 per head of the UK population on diabetes …
Now factor in heart disease .. allergies .. influenza treatment and deaths …. parkinsons .. multiple sclerosis …
How about depression? – another £140 per head UK population per annum. from the estimated cost in 2000:
The total cost of adult depression was estimated at over £9 billion
Source: Imperial College
So we can spend £10 per year on D3 supplements per head of the UK population and reduce NHS spending by say 75% of these amounts (conservatively) – meaning a saving of £271 per head per annum on Cancer, Diabetes and Depression alone. Cancer, diabetes and depression and Schizophrenia are pretty much unknown at the equator.
This amounts to a saving to the NHS potentially of £17.6 billion per annum at a cost of around £650 million for appropriate D3 supplementation and testing …. that’s quite a sum.
Are you getting the picture as to why the Pharma industry is deliberately overplaying the dangers of Vitamin D supplementation?
They can’t patent Vitamin D and they stand to stand to lose an awful lot of money if people are healthy.